REQUEST A DEMO
Total
USD $0.00
Search more companies

DR. KOMARY PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DR. KOMARY PHARMA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

DR. KOMARY PHARMA Kft. is based in Hungary, with the head office in Kecskemet. The company operates in the Pharmacies and Drug Stores industry. DR. KOMARY PHARMA Kft. was incorporated on December 11, 2012. There are currently 15 (2024) people employed by DR. KOMARY PHARMA Kft.. There was a net sales revenue increase of 10.68% reported in DR. KOMARY PHARMA Kft.’s latest financial highlights for 2024. There was a total growth of 26.27% in DR. KOMARY PHARMA Kft.’s total assets over the same period. In 2024, DR. KOMARY PHARMA Kft.’s net profit margin decreased by 0.11%.

Headquarters
Malom koz 16-1.
Kecskemet; Bacs-Kiskun; Postal Code: 6000

Contact Details: Purchase the DR. KOMARY PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the DR. KOMARY PHARMA Kft. report to view the information.
Registered Capital:
Purchase the DR. KOMARY PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the DR. KOMARY PHARMA Kft. report to view the information.
Incorporation Date:
December 11, 2012
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after DR. KOMARY PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.68%
Total operating revenue
10.72%
Operating profit (EBIT)
8.21%
EBITDA
7.82%
Net Profit (Loss) for the Period
6.43%
Total Assets
26.27%
Total Equity
21.74%
Operating Profit Margin (ROS)
-0.07%
Net Profit Margin
-0.11%
Return on Equity (ROE)
-3.15%
Quick Ratio
-0.05%
Cash Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?